126
Views
2
CrossRef citations to date
0
Altmetric
Original Research

How a Patient Personalised Clinical Pharmacy Programme Can Secure Therapeutic Care in an Orthogeriatric Care Pathway (5P Project)?

, , , , , , , , , , , , , , , , ORCID Icon & show all
Pages 1857-1867 | Published online: 21 Oct 2021

References

  • Veronese N, Maggi S. Epidemiology and social costs of hip fracture. Injury. 2018;49(8):1458–1460. doi:10.1016/j.injury.2018.04.01529699731
  • Svedbom A, Hernlund E, Ivergård M, et al. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos. 2013;8(1–2):1–2. doi:10.1007/s11657-013-0137-0
  • Prestmo A, Hagen G, Sletvold O, et al. Comprehensive geriatric care for patients with hip fractures: a prospective, randomised, controlled trial. Lancet. 2015;385(9978):1623–1633. doi:10.1016/S0140-6736(14)62409-025662415
  • Boddaert J, Cohen-Bittan J, Khiami F, et al. Postoperative admission to a dedicated geriatric unit decreases mortality in elderly patients with hip fracture. PLoS One. 2014;9(1):e83795. doi:10.1371/journal.pone.008379524454708
  • Middleton M, Wan B, da Assunçao R. Improving hip fracture outcomes with integrated orthogeriatric care: a comparison between two accepted orthogeriatric models. Age Ageing. 2017;46(3):465–470. doi:10.1093/ageing/afw23227974304
  • Kiesel E, Hopf Y. Hospital pharmacists working with geriatric patients in Europe: a systematic literature review. Eur J Hosp Pharm Sci Pract. 2018;25(e1):e74–e81. doi:10.1136/ejhpharm-2017-001239
  • Beckett RD, Crank CW, Wehmeyer A. Effectiveness and feasibility of pharmacist-led admission medication reconciliation for geriatric patients. J Pharm Pract. 2012;25(2):136–141. doi:10.1177/089719001142260522048929
  • Leguelinel-Blache G, Arnaud F, Bouvet S, et al. Impact of admission medication reconciliation performed by clinical pharmacists on medication safety. Eur J Intern Med. 2014;25(9):808–814. doi:10.1016/j.ejim.2014.09.01225277510
  • Gizzi LA, Slain D, Hare JT, Sager R, Briggs F, Palmer CH. Assessment of a safety enhancement to the hospital medication reconciliation process for elderly patients. Am J Geriatr Pharmacother. 2010;8(2):127–135. doi:10.1016/j.amjopharm.2010.03.00420439062
  • Wolf O, Åberg H, Tornberg U, Jonsson KB. Do orthogeriatric inpatients have a correct medication list? A pharmacist-led assessment of 254 patients in a Swedish University Hospital. Geriatr Orthop Surg Rehabil. 2016;7(1):18–22. doi:10.1177/215145851562529526929852
  • Dooley MJ, Allen KM, Doecke CJ, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004;57(4):513–521. doi:10.1046/j.1365-2125.2003.02029.x15025751
  • Cortejoso L, Dietz RA, Hofmann G, Gosch M, Sattler A. Impact of pharmacist interventions in older patients: a prospective study in a tertiary hospital in Germany. Clin Interv Aging. 2016;11:1343–1350. doi:10.2147/CIA.S10904827713625
  • Donier L, Mondoloni P, Lory P, et al. Conciliation médicamenteuse priorisée sur les patients à risque en chirurgie programmée ou après admission par les urgences. [Priorization of medical reconciliation for patients at risk in scheduled surgery or after emergency admission]. EM-Consulte. 2019;54(2):137–144. doi:10.1016/j.phclin.2018.09.008
  • Hoegy D, Martin J, Barral M, et al. Development of clinical pharmacy programs integrated into patient care pathways using adverse event risks. Res Soc Adm Pharm. 2021. doi:10.1016/j.sapharm.2021.08.005
  • Laroche M-L, Charmes J-P, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63(8):725–731. doi:10.1007/s00228-007-0324-217554532
  • Vo TH, Bardet J-D, Charpiat B, et al. Validation of a tool for reporting pharmacists’ interventions in everyday community pharmacy. J Clin Pharm Ther. 2018;43(2):240–248. doi:10.1111/jcpt.1264229143347
  • Gillespie U, Alassaad A, Henrohn D, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169(9):894–900. doi:10.1001/archinternmed.2009.7119433702
  • Hailu BY, Berhe DF, Gudina EK, Gidey K, Getachew M. Drug related problems in admitted geriatric patients: the impact of clinical pharmacist interventions. BMC Geriatr. 2020;20(1):13. doi:10.1186/s12877-020-1413-731931723
  • Renaudin P, Coste A, Audurier Y, et al. Clinical, economic, and organizational impact of the clinical pharmacist in an orthopedic and trauma surgery department. J Patient Saf. 2018. doi:10.1097/PTS.0000000000000539
  • Serandour N, Corbineau E, Langlois C, Waast D, Huon J-F. Evaluation of the incorporation of clinical pharmacists in a French orthopaedic surgery unit. J Pharm Clin. 2020;39(3):141–150. doi:10.1684/jpc.2020.0442
  • Mekonnen AB, McLachlan AJ, Brien J-AE. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6(2):e010003. doi:10.1136/bmjopen-2015-010003